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Myoglobin inhibits proliferation of cultured human proximal
tubular (HK-2) cells
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Myoglobin inhibits proliferation of cultured human proximal tubular
(HK-2) cells. Following nephrotoxic injury, renal repair is dependent on
tubular regeneration. In the case of myoglobinuric acute renal failure
(ARF), persistence of myoglobin within tubular cells, or sublethal injury
sustained at the height of exposure to it, might retard this process. To test
this hypothesis, a human proximal tubular cell line (HK-2) was cultured
for 24 hours in the absence or presence of clinically relevant myoglobin
concentrations (0.5, 1, 2, 4 mg/mI). Immediately following myoglobin
removal, lethal cell injury (vital dye uptake), lipid peroxidation, and DNA
damage (alkaline unwinding assay) were assessed. The extent of cell
proliferation was estimated over the next four days by a tetrazolium based
(MIT) assay and by determining total intracellular LDH. Myoglobin's
effects on protein and DNA synthesis were also assessed (35S-methionine
and bromodeoxyuridine incorporation, respectively). Myoglobin induced
dose-dependent lipid peroxidation (malondialdehyde generation) and cell
death (up to 80% vital dye uptake with the 4 mg/mI challenge). Although
1 mg/mI myoglobin caused no cell death, it induced nearly complete
growth arrest. This lasted for approximately three days following myoglo-
bin removal from the media. Neither of two control proteins (albumin;
lysozyme) nor a second nephrotoxin (gentamicin; I mg/mi) reproduced
this effect. The 1 mg/mI myoglobin challenge caused an 80 to 90%
depression in protein and DNA synthesis. It also induced significant DNA
damage, as assessed by the alkaline unwinding assay (P < 0.01). Iron
chelation therapy (deferoxamine) mitigated myoglobin-induced cell kill-
ing. However, its addition following myoglobin loading worsened HK-2
outgrowth by exerting a direct anti-proliferative effect. These results
indicate that: (1) sublethal myoglobin toxicity can induce transient prox-
imal tubular cell growth arrest, potentially slowing recovery from ARF; (2)
this effect correlates with, and could result from, heme-induced DNA
damage and a blockade in DNA/protein synthesis; and (3) deferoxamine
can inhibit proximal tubular cell proliferation. This possibility needs to be
considered in designing clinical trials with DFO for myohemoglobinuric
ARF.
cells may exert ongoing effects, potentially altering tubular regen-
eration. Myoglobinuric acute renal failure (ARF) provides a case
in point. During its initiation phase, probably all proximal tubular
cells are subjected to some degree of myoglobin loading via
endocytic reabsorption [61. Although the globin and porphyrin
components are rapidly catabolized within tubular cells, the
released iron is retained [7J. Since iron-catalyzed oxidant stress is
a critical determinant of heme protein nephrotoxicity [8—11],
intracellular iron loading could alter the regenerative process. For
example, iron-induced DNA, protein, or lipid oxidation could
each have profound effects on cell division and repair. Alterna-
tively, since iron is an obligate growth factor, increments in its
intracellular content might accelerate the proliferative process. In
support of the latter possibility are observations that FeSO4
addition to cultured human proximal tubular (HK-2) cells can
stimulate their outgrowth [121. Furthermore, H202-induced oxi-
dant stress and antioxidant agents can exert pro- and anti-
proliferative effects, respectively [12, 13].
Given these considerations, the goals of this study were twofold:
first, to develop a cell culture model of myoglobin-induced
proximal tubular cytotoxicity that simulates some of the essential
features of in vivo heme protein-induced tubular damage; and
second, using this model, ascertain the impact of sublethal
myoglobin toxicity on the ability of proximal tubular cells to
mount a proliferative response.
Methods
Cell culture conditions
Renal functional recovery following the establishment of acute
tubular necrosis (ATN) is dependent on resolution of intratubular
obstruction and repair of the damaged tubular epithelium. The
latter process requires proximal tubular cell regeneration to
re-establish functional and structural tubular integrity [1—31. Fol-
lowing experimental ischemic renal injury, the tubule presumably
can undergo relatively unimpeded repair due to the transient
nature of the original insult [4, 5]. However, following nephrotoxic
injury, persistence of the toxin within sublethally damaged tubular
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All experiments were performed using HK-2 cells, a proximal
tubular cell line derived from a normal adult human kidney [141.
The cells were grown at 37°C in tissue culture flasks (Costar,
Cambridge, MA, USA) with keratinocyte serum free medium
(K-SFM; Gibco/BRL, Grand Island, NY, USA) supplemented
with EGF (5 ng/ml) and bovine pituitary extract (40 rg/ml). For
experimentation, the cultures were trypsinized and transferred to
either 6 or 24 well cluster plates. Unless stated otherwise, they
were plated at a concentration of either —0.25 x 10 or —1 x i05
cells per well (for the 24 well and 6 well plates, respectively). After
allowing a 24-hour post-transfer recovery period, the cells were
used for experimentation, as denoted below.
Model of myoglobin-induced cytotoxicily
Horse skeletal muscle myoglobin (M-0630; lot # 61H7100;
Sigma Chemical, St. Louis, MO, USA) was added to HK-2
subcultures in final concentrations of 0.5, 1, 2, or 4 mg/mI. A 40
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mg/mi stock myogiobin solution was prepared in Hank's balanced
salt solution (HBSS; sonicated to complete solubilization; Gibco).
Prior to application, it was passed through a 0.45 jim filter
(Millex-HV; Millipore Corp. Bedford, MA, USA). After allowing
a 20 to 24 hour exposure, the myoglobin-containing culture media
were removed, the cells were washed twice with HBSS, and fresh
K-SFM was added. The cultures were either studied immediately,
or they were maintained under routine culture conditions for an
additional one to four days to ascertain the rates of cell prolifer-
ation, as described below.
Characterization of myoglobin-induced cytotoxicüy
Assessments of cell viability. Loss of cell viability following
myoglobin treatment was assessed by the % of cells demonstrating
vital dye uptake (ethidium bromide, 8 jig/mI; acridine orange, 2.3jig/mi used as a counterstain; India ink addition to quench
background fluorescence). One hundred cells in each of three
fields were counted.
Lipid peroxidation. Since lipid peroxidation/malondialdehyde(MDA) generation is a correlate of both in vivo and in vitro
myoglobinuric injuiy [8—11] it was sought in HK-2 cells following
myoglobin exposure to help substantiate the relevance of this cell
culture system. To this end, 2 >< 106 cells were cultured in K-SFM
containing 0 to 4 mg/ml myoglobin for 24 hours. After removing
the culture media, the cells were washed X 3 with HBSS. They
were detached from the culture plates with a rubber policeman,
collected by centrifugation, and snap frozen with liquid N2. The
samples were stored at —20°C until the time of assay. MDA
concentrations were determined by a thiobarbituric acid method
[15]. In brief, each sample pellet was suspended in 100 pi 1.15%
KC1 and then 50 jil were mixed with 188 j.tl 0.44 M H3P04 + 75 jil
1.15% KCI + 63 jil 0.6% thiobarbituric acid. The samples were
boiled for one hour, they were brought to pH 6,0 with 100 j.tl
NaOH, and then centrifuged. Supernatant MDA concentrations
were analyzed by HPLC [15, 161 as follows: 100 jil samples were
injected into a Hewlett Packard HPLC 1500 series equipped with
an auto sampler, a multiple wave length detector, and a Supeicosil
column (15 X 0.4 cm LC-18-S; Supelco, Bellefonte, PA, USA).
The mobile phase was 50 m potassium phosphate. Retention
time was 2.9 minutes. Values were expressed as % increase from
control values, adjusting for the number of cells present (total
LDH; see below).
Iron dependence of myoglobin-induced HK-2 cytotoxicily. Previ-
ous work has demonstrated that myoglobinuric renal tubular
injury is iron dependent. This is based on observations that iron
chelation thcrapy attenuates in vivo myohemoglobinuric ARF
[8—101 and mitigates heme protein-induced cytotoxicity in an
isolated proximal tubular segment system [11]. The following
experiment tested whether the present HK-2 model of myoglobin
toxicity is also iron dependent. HK-2 cells were maintained under
routine culture conditions either in the absence or presence of 0.5
mM DFO. After allowing a 20 hour period for cell DFO uptake,
myoglobin was added (either 2 or 4 mg/mi). The DFO pre-treated
cells also had 0.5 mrvi DFO added along with the myoglobin
challenge. Cell viability was assessed 20 hours following the
myogiobin addition by determining % vital dye exclusion.
Myoglobin effects on cell prolifr ration
The effect of myoglobin loading on HK-2 proliferation was
initially assessed at the completion of 24 hours of myoglobin
exposure. Cultures were exposed to either no myoglobin (con-
trols) or myoglobin doses (0.5 or I mg/mi) that were not overtly
cytotoxic (that is, did not cause vital dye uptake; Results). After
completing the 24 hour incubations, total cell mass was assessed
by two independent means: the MTT proliferation assay [14, 17,
181 and total intracellular LDH (each described below). The
absence of tubular cell death in these experiments was confirmed
by demonstrating no increase in vital dye uptake in the myoglobin-
exposed versus the co-cultured normal HK-2 cells.
Next, the long-term impact of myoglobin treatment on cell
proliferation was assessed. HK-2 cells were cultured for 24 hours
in the presence of a sublethal myoglobin challenge (1 mg/mI).
Co-cultured cells maintained under normal conditions served as
controls. At the end of the 24 hour challenge, all of the cultures
were washed (which did not cause cell detachment) and then they
were maintained for an additional 0 to 4 days under normal
culture conditions. Total cell numbers in individual wells were
gauged daily by MTF and total intracellular LDH in individual
wells.
MTT assay. The MTF assay is based on the principle that a
tetrazolium dye (MTT: 3-[4,5,-dimethylthiazol-1-yl]-2,5 diphe-
nyltetrazolium bromide; Sigma Chemicals) is actively transported
by respiring mitochondria, resulting in intramitochondrial forma-
zin precipitation [19]. Therefore, the amount of intra-mitochon-
drial MTT/formazin precipitation is a reflection of total mitochon-
drial mass, and hence, cell number [14, 17, 18]. At the appropriate
time points (from 0 to 4 days following myoglobin removal), 1
mg/ml MTT (in K-SFM) was added to the cultures and incubated
at 37°C for two hours. Then, the culture medium was removed and
dimethylsulfoxide (DMSO) was added to solubilize the intrami-
tochondrial formazin precipitate. The absorbance of the latter was
measured at 570 nm with an ELISA reader, using a 630 nm
reference wave length [14].
LDH assay. To further gauge the extent of proliferation,
additional wells of cells, grown under control or myoglobin
exposure conditions, were washed and then lysed with 10% Triton
X-100. The lysate was assayed for LDH by autoanalyzer technol-
ogy, as previously performed by this laboratory (such as [11]).
LDH, rather than total protein, was used for this purpose to avoid
extraneous extracellular protein contamination (such as from the
culture medium, matrix proteins, any contaminating myoglobin).
Validation of MTT and LDH assays as indices of cell numbers. To
validate the MTT assay and total LDH as markers of HK-2 cell
number, serial dilutions of HK-2 cells [2, 1.5, 1.0, 0.5, and 0 X io
cells] were added to cluster plates and cultured for two days. Cell
numbers were then assessed by both techniques.
The possibility was considered that despite the fact that 1 mg/mI
myoglobin did not cause cell death (vital dye uptake) at the
completion of the 24 hour challenge, delayed cell death (that is,
after myoglobin washout) potentially could have occurred. This
could have diminished cell numbers in the above proliferation
experiments. To exclude this possibility, % vital dye exclusion was
ascertained at 24 and 48 hours following myoglobin washout in
three separate experiments.
Effect of non-iron containing proteins on HK-2 proliferation
The following experiment was undertaken to ascertain whether
myoglobin's anti-proliferative effect was due to myoglobin per se,
or just exogenous protein addition. HK-2 cells were cultured
either in the absence or presence of fatty acid free bovine serum
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albumin (A-6003; Sigma) or lysozyme (L-6876; Sigma), a non-iron
containing protein similar in size to myoglobin. These test pro-
teins were added in concentrations ranging from 1 to 4 mg/mi.
After 20 to 24 hour incubations, the cells were washed and
cultured for 0 to 4 days (N = 3 each). Degrees of proliferation
were gauged by the MTT assay, as noted above. Cell viability at
the completion of the protein challenges was determined by vital
dye exclusion.
Effect of gentamicin on HK-2 cell proliferation. To test whether
any well defined nephrotoxin can reproduce myoglobin's anti-
proliferative effect, the impact of gentamicin on HK-2 cell out-
growth was determined. Since gentamicin is handled by proximal
tubular cells like myoglobin (endocytic uptake, followed by stor-
age within the endolysosomal system), its effects were determined.
HK-2 cells were cultured under normal conditions or in the
presence of 1 mg/ml gentamicin for 24 hours (preliminary data
indicated that this dose, like the 1 mg/ml myglobin dose, caused
no loss of cell viability, as assessed by vital dye uptake). After
completing the 24-hour gentamicin exposure, these cultures and
co-cultured controls were washed. They were then maintained in
culture for an additional three days under routine conditions. Cell
numbers were gauged at the completion of the initial 24-hour
gentamicin loading period and one, two, three, and four days
thereafter by MTT and LDH assay (N = 4 separate determina-
tions on 4 separate cultures at each time point).
Effect of iron chelation therapy on HK-2 cell proliferation
The following experiments were undertaken to ascertain
whether iron chelation therapy, introduced after HK-2 myoglobin
loading, could reverse the block in cellular proliferation. HK-2
cells were exposed to I mg/mI myoglobin for 24 hours, followed by
its washout as noted above. Fresh medium was added 0.5 mM
DFO. Cell proliferation was determined over the next four days.
Co-cultured cells not subjected to myoglobin loading, but treated
in an identical fashion (± DFO), served as controls (N = 3
separate experiments).
Since the above experiments indicated that prolonged DFO
exposure can independently inhibit cell proliferation (Results),
the following experiment ascertained whether short-term DFO
treatment might reverse myoglobin's anti-proliferative effect while
circumventing it own. In brief, the above experiment was repeated
in its entirety except that DFO was applied only for the first 24
hours following myoglobin exposure (N = 3 experiments).
To test whether DFO's anti-proliferative effect on HK-2 cells
was due to iron chelation, rather than a non-specific drug effect,
normal HK-2 cells were cultured in the presence or absence of a
different iron chelator (50 sM 1,10-phenanthroline). Cell numbers
(MTT assay; total intracellular LDH) were assessed each day for
three consecutive days.
Myoglobin 's eJfrct on protein synthetic rates
One potential mechanism by which myoglobin might inhibit cell
proliferation is via a blockade in protein synthesis. To test this
possibility, rates of protein synthesis following 1 mg/mI myoglohin
treatment were gauged by 35S-methionine incorporation as previ-
ously described in detail [201. In brief, 10 sCi/ml 35S-methionine
were added to the culture plates which contained methionine free
K-SFM. After three hours of incubation, the cells were washed
with HBSS, the cells were lysed, the labeled proteins were
solubilized, precipitated with 10% trichloroacetic acid using BSA
as a carrier, and then collected on filters. After washing and air
drying, the amount of precipitated radioactivity was determined
by addition to liquid scintillation fluid (Sigma-fluor; Sigma) and
counting in a scintillation counter. Protein synthetic rates were
determined just after completion of the myoglobin challenge and
one to four days thereafter. Co-cultured cells treated in an
identical fashion except for no myoglobin exposure served as
controls.
Bromodeoxyuridine inco/poration
The following experiment utilized nuclear bromodeoxyuridine
(BrDU) incorporation [21, 221 to gauge DNA synthesis following
myoglobin treatment. Cells were challenged with either 0, 0.5, or
I mg/mi myoglobin for 24 hours. They were washed twice with
HBSS, fresh K-SFM was added, and they were maintained under
routine culture conditions for an additional two days. At that time,
BrDU (50 sM; Sigma) was added to the cultures and the cells
were incubated for six hours. Then, they were fixed with 10%
formalin in phosphate buffered saline (PBS) for 20 minutes,
washed three times with PBS, and permeabilized with 0.2% Triton
X-l00 in PBS for five minutes. The DNA was nicked by incubating
with DNAase I (Worthington Biochemical Co., Freehold, NJ,
USA) for 30 minutes in a buffer containing 40 mi Tris-HC1, pH
7.9, 10 mvi MgC12, and 10 mtvi CaCl2. The plates were washed four
times with PBS, and 5% BSA was added for 15 minutes as a
protein blocking agent. The plates were incubated for 18 hours
with anti-BrDU antibody (Sigma; 1:400 dilution in the blocking
solution). After washing X 3 with PBS, biotinylated anti-mouse
lgG (Vector; Burlingame, CA, USA) was added in a 1:250
dilution (in PBS). Incubations and washings were carried out as
noted above. The biotinylated antibody was detected using Vec-
tastain ABC-AP and alkaline phosphatase substrate kit III (Vec-
tor) according to the manufacturer's instructions. The % of
control cells and post-myoglobin treated cells showing BrDU
nuclear incorporation was determined by counting> 500 cells per
well.
Fluorometric DNA unwinding assay
To assess whether myoglobin-induced oxidant stress might have
culminated in DNA damage, DNA strand breaks were sought by
the DNA unwinding assay [23], as previously utilized by Ueda and
Shah [24]. In brief, 2.5 x 106 cells were cultured with either 0 or
1 mg/mI myoglobin X 24 hours, and they were washed X 3 with
HBSS, and scraped off with a rubber policeman. They were
recovered by centrifugation and suspended in 3 ml HBSS (Ca27
Mg2 free). The suspension was mixed with 9 ml of a hypotonic
lysis buffer (0.87% NH4C1; 10 mt Tris-HCI, pH 7.2) and held at
4°C x 20 minutes. Following centrifugation (1800 g X 20 mm;
0°C), the pellet was suspended in 3 ml of the above buffer,
centrifuged again, and suspended in 1 ml of a buffer containing
0.25 M meso-inositol, 10 m sodium phosphate, 1 mi MgCl2; pH
7.2. The samples (N = 3 for control and myoglohin treated cells)
were then used for the DNA unwinding assay, as originally
described by Birnhoim and Jcvcak [23].
Calculations and statistics
All values are given as means SEM. The number of replicate
experiments which were performed are given in the Figure
legends. Unless stated otherwise, statistical comparisons were
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Fig. 1. A. When cells were incubated with 0, 0.5,
or 1 mg/mI of myoglobin for 20 to 24 hours, no
loss of cell viability resulted, as determined by
vital dye exclusion (NS vs. cells incubated under
normal culture conditions, that is, 0 myoglobin).
Conversely, 2 and 4 mg/mI myoglobin exposure
caused — 30% and 80% vital dye uptake (each
P < 0.002, compared to controls). N  3
separate experiments for each. B. Treating the
cells with 0.5 mtvi DFO for 24 hours prior to
and during a 2 or 4 mg/mI myoglobin challenge
conferred significant protection against
myoglobin-induced vital dye uptake (P < 0.001;
vs. no DFO treatment). DFO had no effect on
cell viability in the absence of the myoglobin
challenge (0 myoglobin). Symbols are: () 0 to
4 mg/mI myoglobin without DFO; (•) 0 to 4
mg/mI myoglobin with DFO. N =  3 separate
experiments for each. Percent live cells was
determined by vital dye exclusion.
The first goal of this study was to establish an in vitro model of
myoglobin toxicity which simulates the essential features of in vivo
heme protein-induced tubular damage. This laboratory has pre-
viously used freshly isolated proximal tubular segments harvested
from myoglobinuric rats or mice to study cell-specific determi-
nants of acute heme protein cytotoxicity [ii]. However, the short
lifespan of freshly isolated tubules in suspension precludes their
use for direct investigation of regenerative events. Hence, in this
study, myoglobin was added to HK-2 proximal tubular cells to
ascertain whether a relevant model of heme protein cytotoxicity
would result. The available data indicate that this is the case. First,
as shown in Figure 1A, myoglobin addition to HK-2 cells caused
dose dependent cytotoxicity: whereas neither 0.5 or 1.0 mg/mI
caused cell death, —-30% and 80% of cells manifested vital dye
uptake following 2 and 4 mg/mI myoglobin exposure, respectively.
Neither BSA nor lysozyme addition reproduced this effect (-—-90%
vital dye exclusion; data not shown), indicating that myoglobin
toxicity was not merely due to "protein loading." Second, DFO
pre-treatment markedly decreased myoglobin cytotoxicity (Fig.
1B). Since DFO has consistently protected against in vivo- and
isolated tubule segment-models of myohemoglobinuric renal in-
jury [8—li], this finding further supports the relevance of the
HK-2 cell line for studying heme protein toxicity. Third, myoglo-
bin's cytotoxic effect correlated with increasing MDA generation
in the residual cell population (Fig. 2). Since lipid peroxidation is
a hallmark of in vivo myohemoglobinuric injury [8, 9], this finding
further speaks to the utility of the employed cell culture system.
Finally, it is noteworthy that myoglobin-initiated lipid peroxida-
tion and cell killing were produced with clinically relevant myo-
globin concentrations ( 4 mg/ml). In this regard, during the
initiation phase of experimental myohemoglobinuric ARF, urine
myoglobin concentrations of —35 mg/mI are typically observed
[25, 26].
Fig. 2. Culturing cells with myoglobin for 24 hours caused a dose dependent
increase in MDA concentrations, significant at a concentration of> 1 mg/mI
(P < 0.01; N = 3 determinations at each concentration). The values are
expressed as a % increase over that observed in co-cultured controls.
Since recovery from ARF requires regeneration of the dam-
aged tubular epithelium, the principal goal of this study was to
determine myoglobin's impact on HK-2 cell proliferation follow-
ing sublethal damage. To gain an initial insight into this issue, cells
were incubated with sublethal myoglobin doses (0.5 and I mg/mI),
and after 24 hours cell numbers were assessed by the MTTassay
and total intracellular LDH. The validity of these markers of
HK-2 proliferation was first demonstrated by essentially perfect
correlations between them and cell numbers in serial dilution!
outgrowth experiments (Fig. 3). As shown in Figure 4, after 24
hours of culture in the presence of either 0.5 or 1 mg/mI of
myoglobin, significant reductions in cell number/mass were appar-
ent. Given that the normal HK-2 cell doubling time is —36 hours,
and since neither of these myoglobin doses caused cell death (as
assessed by vital dye exclusion), these findings suggested that
myoglobin had induced HK-2 growth arrest.
To further pursue this possibility, cells were pretreated with I
mg/mI of myoglohin for 24 hours, the myoglobin was removed
from the media, and then the cultures were maintained for an
additional four days. As shown in Figure 5, the myoglobin loaded
performed by unpaired Student's f-test (in all proliferation exper-
iments, the results for the experimental groups were contrasted to
those obtained in co-cultured, independent control groups). If one
set of control values was compared to more than one experimental
group (such as in the BrDU experiments), unpaired Student's
t-test with the Bonferroni correction was applied.
Results and Discussion
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Fig. 3. Serial dilutions of HK-2 cells were plated
and cultured fbr two days, followed by total
intracellular LDH (A) and MTT assay (B). An
essentially perfect correlation (r > 0.99) was
noted between the number of plated cells and
total LDH/MTT uptake, validating these two0 0.5 1 1.5 2 2.5 tests as markers of HK-2 cell numbers. (N 2
Cell number x io separate experiments for each data point). TheSEM was < the depicted symbols.
Fig. 4. Cell numbers were assessed 24 hours
following culture in the presence of 0, 0.5, and 1
mg/mi myoglobin. Stepwise reductions in both
total (A) LDH and (B) MIT values were
apparent (% of the values observed with the 0
myoglobin controls). Since neither the 0.5 nor
the 1.0 mg/mI myoglobin dose caused a loss of
cell viability (assessed by vital dye exclusion),
and since the myoglobin treatment did not
cause HK-2 cell detachment (a potential
artifact which could cause reductions in cell
mass), these results suggested that myoglobin
had induced growth arrest (0 myoglobin, N =
16; 0.5 or I mg/mI myoglobin, N = 8 each).
cells continued to manifest a marked reduction in outgrowth for
—3 additional days. By the fourth day post myoglobin washout,
some improvement in cell proliferation was apparent (Fig. 5). Of
note is that neither BSA nor lysozyme treatment had any impact
on identically conducted cell outgrowth experiments (data not
shown), indicating that myoglobin's negative impact was not
simply a "protein loading" effect. Finally, when the cells were
examined for vita! dye uptake one to two days into these out-
growth experiments, no loss of cell viability was observed. This
indicates that delayed cell death did not account for the dimin-
ished cell numbers. In sum, these experiments demonstrate that:
(1) myoglobin can induce HK-2 growth arrest; (2) this effect
persists beyond the period of acute myoglobin exposure (a point
with obvious potential clinical relevance), and (3) this antiprolif-
erative effect represents a transient, rather than an irreversible,
defect.
Since myoglobin toxicity is iron dependent (such as Fig. lB
data), the next issue to he addressed was whether DFO treatment
could reverse myoglobin's growth suppressive effect. To test this
possibility, cells were continuously exposed to DFO after they had
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Fig. 5. Cells were treated with I mg/mi
myoglobin for 24 hours, the myoglobin was
removed, and then cell outgrowth was assessed
over 4 additional days by (A) LDH or (B) MTT
assay. Co-cultured, nonmyoglobin exposed cells
treated in an identical manner served as
controls (E). Whereas the normal cells
manifested curvilinear increases in LDH and
MIT values, the myoglobin treated cells (0)
demonstrated virtually no increments for
—three days following myoglobin washout.
After three days, recovery of cell proliferation
was noted. Values are given as a % increase
from time 0 values (the time of myoglobin
washout). SEM if not depicted = less than the
depicted symbols. N > 4 determinations at each
time point (P < 0.00005 at days 1, 2, 3, and 4,
compared to the control cells).
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Fig. 6. A, B. Effect of DFO treatment on HK-2
cell outgrowth following 1 mg/mI myoglobin
loading. All of the cultures demonstrated an
absence of proliferation until — day 3. DFO
treatment during this time only served to
supppress cell outgrowth, as evidenced by the
fact that the DFO-treated cells did not manifest
the normal proliferative upsurge at -- day 3.
Thus, DFO worsened, rather than improved,
cell proliferation rates. C, D. DFO's negative
effect on HK-2 outgrowth was not confined to
myoglobin loaded cells since it also blocked
normal HK-2 cell proliferation. In data not
shown, 50 j.rM 1,10 phenanthroline reproduced
DFO's anti-proliferative effect. Symbols are:
(El) —DFO; (0) +DFO. (All values are given
as a % increase from time zero. N  3
determinations at each time point. The SEM
was < the size of the symbol if no SEM bars are
given).
completed 20 to 24 hours of myoglobin loading. As shown in
Figure 6 A and B, DFO did not improve HK-2 proliferation from
days 1 to 3 post myoglobin washout, whether assessed by MTT or
LDH assay. Of particular note, DFO treatment blocked the
normal proliferative "upsurge" that normally occurs three to four
days post-myoglobin loading. This negative impact was not con-
fined to the myoglobin-loaded cells, because DFO also retarded
normal HK-2 cell outgrowth (Fig. 6 C, D). That 1,10-phenan-
throline reproduced this latter growth suppressive effect (data not
shown) indicates that DFO's negative impact was likely due to
iron chelation, not DFO toxicity, per se. In subsequent experi-
ments, we tested whether short-term DFO therapy (for 24 hr
immediately post-myoglobin treatment) might reverse myoglo-
bin's growth suppressive effect while, at the same time, averting its
own. However, this protocol also failed to exert a beneficial
influence (data not shown). Thus, these findings suggest a thera-
peutic paradox: whereas iron chelation therapy mitigates the
initial expression of hemc protein nephrotoxicity, it may also retard
recoveiy from it. This result is by no means surprising since it has
previously been demonstrated that DFO, as well as other iron
chelators, can inhibit cell proliferation by blocking DNA synthesis
[27, 281. This may occur via inhibition of ribonucleotide reductase,
the enzyme which mediates the free-radical reduction of ribo- to
deoxyribonucleotides [271. Since this is a rate limiting step in
DNA synthesis, cell proliferation is attenuated. Alternatively, iron
chelation may also inhibit the expression of cyclin A-dependent
p33cdk2 kinase [281.
A number of nephrotoxins can suppress protein synthesis
[29—31]. Were myoglobin to exert this influence, it could help to
explain its antiproliferative effect. Hence, 35S-methionine incor-
poration was determined in myoglobin loaded and control HK-2
cells. As depicted in Figure 7A, following 24 hours of a 1 mg/mI
myoglobin challenge, an approximate 85% suppression of 35S-
methionine uptake was observed. This finding cannot simply be
explained by diminished cell numbers, since factoring the 35S-
methionine data by the total cell mass (LDH) still revealed an
approximate 65% reduction in protein synthesis (Fig. 7B).
Whether reduced protein synthesis was a cause of the diminished
cell proliferation or a marker of it remains unknown. As shown in
Figure 7C, once the myoglobin was removed from the cultures,
the control and the myoglobin loaded cells mounted essentially
parallel increments in 35S-methionine incorporation. This con-
ceivably could have allowed the cells to escape from the myoglo-
bin-induced growth arrest.
To further define the characteristics and possible basis for
myoglobin's anti-proliferative effect, DNA synthetic rates were
gauged by BrDU incorporation. Specifically, the % cells manifest-
ing BrDU uptake two days following completion of a 0.5 or 1
mg/ml myoglobin challenge was assessed. Co-cultured normal
HK-2 cells served as controls. Whereas 44 4% of normal cells
demonstrated BrDU positivity (Fig. 8), the cells previously treated
with 0.5 or 1 mg/ml myoglobin manifested 25 9% and 4 4%
BrDU positivity, respectively. Thus, these data provide indepen-
dent confirmation of the principal conclusion from the LDH and
MTT data: that sublethal myoglobin exposure induces a profound
antiproliferative effect. The BrDU data also raise the possibility
that a direct block in DNA replication might exist, possibly
causing or contributing to this result.
A likely explanation for the myoglobin-induced block in BrDU
incorporation could be iron-mediated oxidant DNA damage. In
this regard, it is noteworthy that DNA strand breaks are readily
induced by iron dependent oxidant stress [321. To explore this
possibility, we used the highly sensitive DNA unwinding assay to
determine whether a sublethal myoglobin exposure (1 mg/mI) had
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Fig. 7. A. Absolute cpms 35S-methionine incorporated into cells after 24 hours in culture in the absence or presence of] mg/mI myoglobin. An approximate
85% suppression was noted in the myoglobin exposed cells (P < 0.00005; N = 3). B. Factoring the 35S-methionine incorporation by the prevailing cell
mass (as assessed by intracellular LDH) indicated that the above difference in protein synthesis could not be solely due to differences in cell number
(0 vs. I mg/mI myoglobin, P < 0.001). C. Following myoglobin washout from the culture medium, the cells (0) regained what appeared to be a normal
protein synthetic rate (that is, the same approximate slope as observed in the nonmyoglobin exposed cells, u)
Fig. 8. Effect of myoglobin treatment on BrDU incorporation by HK-2 cells. A. Normal HK-2 cells showing a high frequency of nuclear BrDU positivity.
Conversely, cells treated with 1 mg/mI myoglobin for 24 hours and then allowed a 48-hour recovery period showed a low frequency of BrDU positivity
(B). In addition, the cells after, but not before, fixation, had a more angular appearance. The % BrDU positivity for these experiments are depicted in
panel C. P < 0.0001 for each myoglobin group vs. the controls (unpaired t-test/Bonferroni correction; controls, N  9 determinations for each).
damaged HK-2 DNA. The unwinding assay is based on the
principal that the rate of DNA unwinding in alkaline solutions is
dependent on the length of the DNA. Hence, strand breaks (even
I per chromosome) accelerates this process [23]. As shown in
Figure 9, significantly greater DNA unwinding under alkaline
conditions was observed in the myoglobin treated cells. Clearly
then, 1)NA damage had occurred. Whether these strand breaks,
and/or oxidant damage to DNA bases, were directly responsible
for the decreased proliferation remains an untested, but appealing
hypothesis.
A remaining question is whether the myoglobin-induced block
in cell proliferation was a completely non-specific response, that
is, could it be reproduced by any toxic agent? This seemed most
unlikely given observations that H,02 [13] and FeSO4 [12] can
increase tubular cell proliferation, possibly by enhancing ribonu-
cleotide reductase activity [27]. On the basis of these results, one
might anticipate that myoglobin would exert a growth stimulatory,
rather than an inhibitory, effect. The explanation for this seeming
paradox remains unknown, but it may stem from marked differ-
ences in rates and degrees of iron/free radical generation. For
example, an H202 challenge is rapidly dissipated due to intracel-
lular catalase activity. Conversely, FeSO4 has very limited intra-
cellular access. I lowever, myoglobin is actively transported into
tubular cells and once there, it represents a persisting iron burden.
These differences in cellular kinetics could conceivably underlie
these seemingly descrepant observations.
To further make the point that a persisting block in cell
proliferation is not a necessary consequence of nephrotoxin
exposure, the impact of a borderline toxic gentamicin concentra-
tion (1 mglml) on HK-2 proliferation was assessed. After a 24
hour exposure, gentamicin caused an approximate 20% decrease
in cell numbers, as assessed by MTT and LDH assay (1' < 0.01).
Since this gentamicin dose caused no increased vital dye uptake
(> 90% for the control and gentamicin groups), it appears that
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Fig. 9. Effect of 1 mg/mi myoglobin treatment X 24 hours on DNA
unwinding. Under alkaline conditions, the myoglobin treated cells (0)
manifested significantly increased unwinding, consistent with DNA strand
breaks compared to controls (LI). The values are statistically different
after both 30 minutes and 90 minutes under alkaline conditions (P <
0.005). If one extrapolates the line back to time zero, 61 4% and 77
2% intact DNA values were obtained for myoglobin and control cells,
respectively (P = 0.02; N = 3; the SEM was less than the symbol sizes).
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Fig. 10. Effect of I mg/mi gentamicin (0) exposure for 24 hr on HK-2
proliferation. At the completion of 24 hr of gentamicin exposure, cell
numbers were reduced by —20% (assessed by MTT and LDH assay) (P <
0.01, compared to co-cultured controls, LI). This is consistent with
gentamicin's ability to inhibit protein synthesis [30]. However, following
gentamicin removal from the cultures, a normal proliferative response was
observed (similar upward slope to that seen in the normal cells). This
result was in marked contrast to that observed in the myoglobin washout
experiments.
gentamicin had retarded cell proliferation by its ability to inhibit
protein synthesis [30]. However, once the gentamicin was re-
moved from the culture medium, a normal proliferative response
was observed (Fig. 10). This further makes the point that myo-
globin's ability to induce persisting growth arrest should not
simply he viewed as a non-specific consequence of "nephrotoxic-
ity".
In conclusion, the present study demonstrates that following a
20 to 24 hour period of myoglobin exposure, a marked suppres-
sion of proximal tubular cell proliferation may result. Correlates
of this growth suppression, and potential causes of it, include a
striking decrease in DNA synthesis (BrDU incorporation), direct
DNA damage (strand breaks), and a marked suppression of
protein synthesis. Whether these results, obtained with an immor-
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